In December 2020, the vaccine was authorized with the US Foodstuff and Drug Administration and prequalified by WHO for use in men and women eighteen years of age and more mature (apart from Expecting and breastfeeding Females) for protection against Ebola virus disease attributable to Zaïre Ebola virus. [86] Whilst https://virusbola.site/